Agora Announces RTE Telehealth, A Webinar Exploring the Impact of AI and AR/VR in Virtual Healthcare
13 Nov 2023
The dual session will explore how emerging technologies can improve patient interaction and healthcare delivery in telehealth
SANTA CLARA, Calif., Nov. 13, 2023 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, has announced its RTE Telehealth webinar event, designed to help healthcare professionals chart the course toward a future where state-of-the-art technologies will transform the way we deliver and receive healthcare and drive better patient outcomes. The virtual event will examine how augmented reality (AR), virtual reality (VR), and artificial intelligence (AI) are transforming telehealth, highlighting their potential to enhance the entire healthcare experience from research, training and general workflows to diagnosis, treatment, and patient education.
The telemedicine market is projected to grow to $450 billion by 2032. As telemedicine breaks down geographical barriers and makes healthcare more inclusive, it's expected to become an integral component of the medical industry, signaling a paradigm shift in how medical services are delivered and experienced. Integrating AR/VR and AI holds tremendous potential to revolutionize the telehealth industry, transforming medical training, patient diagnosis and education, and enabling greater personalization and collaboration through data-powered insights and highly immersive simulated environments.
"The integration of AI and AR/VR into telehealth is not just an upgrade—it's a breakthrough," said
Wyatt Oren, Director of Telehealth at Agora. "These advancements promise to redefine accessibility and efficacy in healthcare, paving the way for a future where distance and resources are no longer barriers to quality patient care, offering unprecedented accessibility and creating immersive training platforms for medical professionals. With AR and VR expanding access and enriching training, and AI enhancing doctor-patient connections in real-time, we're witnessing a new age of medical collaboration and innovation."
RTE Telehealth will unpack how AI's data-driven insights and the immersive capabilities of AR/VR have advanced the industry through two informative sessions. AR/VR in Telehealth will discuss AR/VR's role in offering engaging patient education, remote surgical assistance, and improving care delivery, while AI in Telehealth will address the cost-effectiveness and accuracy of AI applications in virtual consultations, transcription, translation, and the Internet of Medical Things (IoMT).
Lending their expertise to the series is a panel of distinguished speakers, including:
Pearly Chen, Vice President, HTC VIVE
Gil Margolin, Chief Technology Officer, Talkspace
Christopher Brickler, CEO at MyndVR
Chris Mathew, Chief Growth Officer at Sniffle
Chris Olson, Strategic Advisor, Canary Speech
Daniel Andreev, Co-Founder and CPO, PsyTech VR
Wyatt Oren, Director of Telehealth at Agora
Max Randall, Account Executive at Agora
Through their collective insights, speakers will clarify the roles of AI and AR/VR in telehealth, highlighting the technological nuances and potential benefits of these innovations, thrusting healthcare delivery into a new era of accuracy and patient immersion. Together, these technologies are making top-tier care more accessible and cost-effective, and ensuring that it is delivered with unparalleled precision and performance.
For more information about Agora's webinar series and to register, please visit: https://rte2023-telehealth.agora.io/register
About Agora
Headquartered in Santa Clara, California, Agora is a pioneer and global leader in Real-Time Engagement Platform-as-a-Service (PaaS), providing developers with simple, flexible, and powerful application programming interfaces, or APIs, to embed real-time voice, video, interactive live-streaming, chat, whiteboard, and artificial intelligence capabilities into their applications.
SOURCE Agora, Inc.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.